Kurt A. Jaeckle - Concepedia

Author

Kurt A. Jaeckle

Also Known As

D. W. Northfelt, J. Perry, K A Jaeckle, K Jaeckle, K. A Jaeckle, K. A. Jaeckle, K. JAECKLE, K. Jaeckle, K.A. Jaeckle, KURT A. JAECKLE

244

Publications

19.3K

Citations

H-Index

100

Concepts

All Affiliations

Mayo Clinic in Florida The University of Texas MD Anderson Cancer Center Jacksonville College WinnMed Mayo Clinic

About

Kurt A. Jaeckle is an author at Mayo Clinic in Florida specializing in medicine, neuro-oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	53	4.2K
2	Health Sciences	19	23	1.7K
3	Allergy	2	2	66
4	Public Health	1	1	22
5	Social Sciences	1	1	17

Kurt A. Jaeckle

105

Publications

17.1K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, New England Journal of Medicine	2014	2.7K
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases Paul D. Brown, Kurt A. Jaeckle, Karla V. Ballman, JAMA	2016	1.6K
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial Mark R. Gilbert, Meihua Wang, Kenneth Aldape, Journal of Clinical Oncology	2013	1.1K
Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Journal of Clinical Oncology	1999	895
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study Evanthia Galanis, Jan C. Buckner, Matthew J. Maurer, Journal of Clinical Oncology	2005	690
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Michael Glantz, Kurt A. Jaeckle, Marc C. Chamberlain, PubMed Neuro-oncologySurgical OncologyMedicineIntrathecal Sustained-release CytarabineCsf Disease	1999	526
Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas Howard A. Fine, William D. Figg, Kurt A. Jaeckle, Journal of Clinical Oncology	2000	425
Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer Francisco A. Luque, Henry Furneaux, R Ferziger, Annals of Neurology	1991	399
Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis Michael Glantz, Suzanne LaFollette, Kurt A. Jaeckle, Journal of Clinical Oncology	1999	398
Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study Evanthia Galanis, Kurt A. Jaeckle, Matthew J. Maurer, Journal of Clinical Oncology	2009	354

Page 1